Is Your Biotech IP Already at Risk Without You Knowing?
Biotech executives rarely ask whether their intellectual property is perfectly secure. The real question, often unspoken, is whether they would know if something had already gone wrong. Across growth-stage biotech firms, proprietary formulas and trade secrets represent years of sunk cost, competitive differentiation, and future valuation. Yet most organizations assess IP protection through a narrow […]